Response to: “Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma” by Simone Famularo, MD, Matteo Donadon, MD, PhD, Federica Cipriani, MD, Luca Aldrighetti, MD, PhD, Franco Trevisani, MD, Guido Torzilli, MD, PhD, FACS

Get full text